Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

iBio Inc Closes $4.2 Million Public Offering


Monday, 29 Apr 2013 08:46am EDT 

iBio Inc announced that it has closed an underwritten public offering of 8,925,000 shares of the Company's common stock and warrants to purchase 3,570,000 shares of the Company's common stock. The securities were sold as a unit with each unit consisting of one share of common stock and 4/10ths of a warrant to purchase one share of common stock. The public offering price of each unit was $.48 resulting in gross proceeds of approximately $4,284,000 before underwriting discounts and other expenses. iBio plans to use proceeds of the offering for working capital, including further development of iBio's product candidates and technology, business development and for other general corporate purposes. Roth Capital Partners acted as sole manager for the offering. 

Company Quote

0.72
0.02 +2.86%
19 Dec 2014